Vraylar 3 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FFHQ0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,029
Award facts
- Contract value 100% obligated
- $11,029.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,029.24 to AmerisourceBergen Drug Corp for the supply of Vraylar 3 mg capsules (30-count units) on September 8, 2025, with completion expected by September 9, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's federal contract awards with DLA demonstrate its capability to meet competitive procurement requirements across multiple therapeutic domains, including neurological treatments such as Vraylar. The DLA Troop Support Medical contract vehicle supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a primary supplier within the federal pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FFHQ0?
SPE2DB25FFHQ0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FFHQ0 worth?
The government has obligated $11,029 on SPE2DB25FFHQ0.
Is contract SPE2DB25FFHQ0 an order under another contract?
Yes. SPE2DB25FFHQ0 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFHQ0 competed?
The extent of competition for SPE2DB25FFHQ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award